United States · FDA National Drug Code directory
IPOL
A source-listed medicine record.
Factual source checks only. This page is not a clinically reviewed monograph. Historical or discontinued records may be included; listing does not confirm approval, current availability or pharmacy stock.
Medicine identity
- Source reference
- 50090-1693_3b033b74-e5f4-48a4-ba99-260ce6578a56
- Product NDC
- 50090-1693
- Form
- INJECTION, SUSPENSION
- Composition / generic term
- POLIOVIRUS TYPE 1 ANTIGEN (FORMALDEHYDE INACTIVATED), POLIOVIRUS TYPE 2 ANTIGEN (FORMALDEHYDE INACTIVATED), and POLIOVIRUS TYPE 3 ANTIGEN (FORMALDEHYDE INACTIVATED)
- Labeler
- A-S Medication Solutions
- Marketing category
- BLA
- Marketing start / end (source format)
- 19901221
- Source listing expiry
- 20261231
Source-listed ingredients
- POLIOVIRUS TYPE 1 ANTIGEN (FORMALDEHYDE INACTIVATED) — 40 [D'ag'U]/.5mL
- POLIOVIRUS TYPE 2 ANTIGEN (FORMALDEHYDE INACTIVATED) — 8 [D'ag'U]/.5mL
- POLIOVIRUS TYPE 3 ANTIGEN (FORMALDEHYDE INACTIVATED) — 32 [D'ag'U]/.5mL
These values do not establish equivalence or a dose recommendation.
Packages
- 1 VIAL, MULTI-DOSE in 1 PACKAGE (50090-1693-9) / 5 mL in 1 VIAL, MULTI-DOSE (50090-1693-0) · 50090-1693-9
Source and coverage
Open FDA National Drug Code directory →
Snapshot retrieved: 2026-09-17. This is the acquisition date, not a medical review date.
Clinical information, images and comparisons appear only when separately reviewed for this record. Coverage may be incomplete. Ask a pharmacist or clinician about your treatment.
Browse United States records →